Myriad Genetics, Inc. <MYGN.O>: Piper Sandler cuts to Underweight from Overweight; cuts target price to $2 from $5.45
MYGN•Related News
The Americas’ oil bonanza will outlast the Iran conflict: Bousso
XLE•
Tempus AI, Inc. Raises to Overweight From Neutral; Raises Target Price to $76 From $56
TEM•
North Sea gas maintenance schedule: Revises Barrow (North Terminal) outage
XLE•
GM Korea August Sales 23,042 Units, Up 9.4% Y/Y
GM•
Apollo Says Eight New Interim Lenders Join Bidco Facilities Agreement As Of Aug. 31, 2026 For EasyJet Deal
APO•